The following publication of Philip James’ book last summer, it has been featured in an article in today’s Daily Telegraph. Follow the link below if you would prefer not to buy the paper! http://www.telegraph.co.uk/lifestyle/11376969/The-miraculous-healing-powers-of-oxygen.html
Posts Categorized: MS News
Stem cell study: positive results for relapsing remitting MS
Source MS Society: Treating people with relapsing remitting MS with stem cell transplantation therapy might help prevent relapses and prevent disability progression, according to a smallclinical trial carried out in the US. Read on
Fingolimod (Gilenya) not effective in primary progressive MS
Source MS Society: “Note – While these results are disappointing, they do not affect the proven effectiveness of Gilenya in relapsing remitting MS.” Novartis – the pharmaceutical company that manufacture Gilenya – carried out a global phase 3 clinical trial involving 940 people with primary progressive MS, known as INFORMS. The trial aimed to evaluate… Read more »
Bone mineral density is reduced in people with MS
Source MSRA.org: Evidence has been accumulating over recent years that people with MS are at increased risk of osteoporosis and bone fractures in comparison to the general population. Osteoporosis is a progressive loss of bone minerals leading to fragile bones that are at greater risk of fracturing. It is common in the ageing population and… Read more »
MS Study Day
MS STUDY DAY 2014: AN OVERVIEW Who was the event aimed at? The study day was aimed at people newly diagnosed with MS, interested in therapies or currently on therapies. When did it happen? The event was held on Friday, 26th September 2014… at Twickenham Stadium. I was unable to attend, can I still view… Read more »
Tecfidera now available from the NHS in England and Wales
Source MS Society: Published date: 27 Nov 2014 at 1:01PM From today Tecfidera, a treatment for relapsing remitting MS, will be made available on the NHS in England and Wales; it is already available in Northern Ireland and Scotland. Read on.
MS Society responds to fitness for work announcements
Source MS Society: A major independent review was published yesterday on the Work Capability Assessment – the test designed and used by the Department of Work and Pensions (DWP) to determine the entitlement of disabled welfare claimants to Employment and Support Allowance (ESA). Read on.
Fingolimod (Gilenya) not effective in primary progressive MS
Fingolimod (Gilenya) not effective in primary progressive MS Source MS Society: “Note – While these results are disappointing, they do not affect the proven effectiveness of Gilenya in relapsing remitting MS.” Novartis – the pharmaceutical company that manufacture Gilenya – carried out a global phase 3 clinical trial involving 940 people with primary progressive MS,… Read more »
Work starts on Cardiff University brain imaging centre
Source BBC: Work to build a £44m brain imaging centre to help experts better understand the causes of conditions like dementia and multiple sclerosis has begun in Cardiff. Researchers at the Cardiff University site will use mapping techniques to get a more detailed look at how the brain works. Read on.
The disability benefit Employment and Support Allowance (ESA) has featured heavily in the news
Source MS Society: Published date: 30 Oct 2014 at 1:23PM The disability benefit Employment and Support Allowance (ESA) has featured heavily in the news in the last 24 hours. While the BBC has reported leaked documents about the future of payments, a major announcement on the new company replacing the assessment provider Atos has also… Read more »
